Cargando…

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933621/ https://www.ncbi.nlm.nih.gov/pubmed/35313459 http://dx.doi.org/10.2147/IJN.S362734

Ejemplares similares

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang, Qiumo, et al.
Publicado: (2020)

Corrigendum to: iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
Publicado: (2022)

siRNAdb: a database of siRNA sequences
por: Chalk, Alistair M., et al.
Publicado: (2005)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002)

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
Publicado: (2021)

Corrigendum to “Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor” [Data Brief 3 (2015) 117–119]
por: Brioschi, Maura, et al.
Publicado: (2015)

Identification of metabolically stable 5΄-phosphate analogs that support single-stranded siRNA activity
por: Prakash, Thazha P., et al.
Publicado: (2017)

A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis
por: Cui, Yongzhi, et al.
Publicado: (2021)

Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA
por: Zhang, Haiyang, et al.
Publicado: (2018)

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

Corrigendum to “Expression of HGF and c-Met Proteins in Human Keratoconus Corneas”
por: You, Jingjing, et al.
Publicado: (2016)

siRNA-mediated inhibition of endogenous brain-derived neurotrophic factor gene modulates the biological behavior of HeLa cells
por: Sun, Chun-Yan, et al.
Publicado: (2021)

Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression
por: Li, Zhefeng, et al.
Publicado: (2018)

siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
por: Kim, Dae Won, et al.
Publicado: (2009)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells
por: Ambrosio, Leanne, et al.
Publicado: (2020)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

siRNA could be a potential therapy for COVID-19
por: Ghosh, Sanhita, et al.
Publicado: (2020)

Chitosan nanoparticle-delivered siRNA reduces CXCR4 expression and sensitizes breast cancer cells to cisplatin
por: Yu, Shaonan, et al.
Publicado: (2017)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

Preparation of Exosomes for siRNA Delivery to Cancer Cells
por: Faruqu, Farid N., et al.
Publicado: (2018)

SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling
por: Chen, Tai-yu, et al.
Publicado: (2022)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells
por: Alshehri, Abdullah, et al.
Publicado: (2018)

Corrigendum to “α-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism”
por: Calla-Choque, Jaeson Santos, et al.
Publicado: (2016)

[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
por: Račkauskas, Rokas, et al.
Publicado: (2023)

Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
por: Hess, Timo, et al.
Publicado: (2023)

SiRNA-mediated PIAS1 silencing promotes inflammatory response and leads to injury of cerulein-stimulated pancreatic acinar cells via regulation of the P38MAPK signaling pathway
por: Chen, Ping, et al.
Publicado: (2021)

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
por: Koizumi, W, et al.
Publicado: (2014)

Visualization of self-delivering hydrophobically modified siRNA cellular internalization
por: Ly, Socheata, et al.
Publicado: (2017)

Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Publicado: (2020)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
por: Lin, Dan, et al.
Publicado: (2021)

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway
por: Shu, Xiong, et al.
Publicado: (2023)

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
por: Liu, Qinhua, et al.
Publicado: (2022)

Publisher Correction: Pathways of cellular internalisation of liposomes delivered siRNA and effects on siRNA engagement with target mRNA and silencing in cancer cells
por: Alshehri, Abdullah, et al.
Publicado: (2018)

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]
Publicado: (2022)

The Role of the Arabidopsis Exosome in siRNA–Independent Silencing of Heterochromatic Loci
por: Shin, Jun-Hye, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_prmprepjkaaern8tt3iiu8nb70